Calpain inhibitor I reduces the activition of nuclear factor-κB and organ injury/dysfunction in hemmorrhagic shock

FASEB Journal

Volumn 15, Issue 1, 2001, Pages 171-186

  McDonald, M C ^a   Mota Filipe, H ^a   Paul, A ^a   Cuzzocrea, S ^a   Abdelrahman, M ^a   Harwood, S ^a   Plevin, R ^a   Chatterjee, P K ^a   Yaqoob, M M ^a   Thiemermann, C ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Calpain; Cyclo oxygenase; Endotoxin; Hemorrhage; Multiple organ failure; Nitric oxide; Reperfusion injury

Indexed keywords

CALPASTATIN; CHYMOSTATIN; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DNA DEGRADATION; DRUG EFFECT; ELECTROPHORETIC MOBILITY; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HEMORRHAGIC SHOCK; ISCHEMIA; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; RESUSCITATION; SIGNAL TRANSDUCTION;

ANIMALS; BLOOD PRESSURE; CYCLOOXYGENASE 2; DNA; GLYCOPROTEINS; HEART RATE; I-KAPPA B PROTEINS; INTESTINES; ISOENZYMES; KIDNEY; LIPASE; LIPOPOLYSACCHARIDES; LIVER; LUNG; MACROPHAGES; MICE; MUSCLE, SMOOTH, VASCULAR; MYOCARDIUM; NF-KAPPA B; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PANCREAS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEIN BINDING; RATS; REPERFUSION INJURY; RESUSCITATION; SHOCK, HEMORRHAGIC; SYNDROME;

ANIMALIA; MURINAE;

EID: 17744399022     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.99-0645com     Document Type: Article

References (59)

1. The calpains
2. Calpain: New perspectives in molecular diversity and physiological-pathophysiological involvement
3. Calpain inhibition: An overview of its therapeutic potential
4. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor
5. I kappa B: A specific inhibitor of the NF-kappa B transcription factor
6. Mutual regulation of the transcription activator NFkappa B and its inhibitor, I kappa B
7. Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB
8. Structure, regulation and function of NF-kappa B
9. Inhibitors of proteosome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-kappa B
10. Serine and cysteine proteinase inhibitors prevent nitric oxide production by activated macrophages by interfering with transcription of inducible NO synthase gene
11. Analysis of the signal transduction in the induction of nitric oxide synthase by lipoteichoic acid in macrophages
12. Inhibition of IkappaB-alpha and Ikappa-B-beta proteolysis by calpain inhibitor I blocks nitric oxide synthase synthesis
13. Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor-alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells
14. Involvement of nuclear factor kappa B in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes
15. Hemorrhagic and obstructive shock in pediatric patients
16. Bactericidal/permeability-increasing protein (rBPI21) in patients with hemorrhage due to trauma: Results of a multicenter phase II clinical trial
17. Pattern of organ failure following severe trauma
18. Therapeutic approaches for clinical ischemia and reperfusion injury
19. 2+
20. Reperfusion of rat heart after brief ischemia induces proteolysis of calspectin by calpain
21. Downregulation of calpastatin in rat heart after brief brain ischemia and reperfusion
22. Mechanisms of calpain proteolysis following traumatic brain injury: Implications for pathology and therapy: A review and update
23. Protective effects of calpain inhibitors against neuronal damage caused by cytotoxic hypoxia in vitro and ischemia in vivo
24. Calpain as a novel target for treating acute neurodegenerative disorders
25. An alpha-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotective
26. Six-hour window of opportunity for calpain inhibition in focal cerebral ischemia in rats
27. Calpain is a mediator of preservation-reperfusion injury in rat liver transplantation
28. Calpain mediates ischemic injury of the liver through modulation of apoptosis and necrosis
29. Calcium-activated neutral protease inhibitor (E-64c) and reperfusion from experimental myocardial infarction
30. Role of calcium-activated neutral protease (calpain) in cell death in cultured neonatal rat cardiomyocytes during metabolic inhibition
31. Calpain activity alters rat myocardial subfractions after ischemia and reperfusion
32. Protective effect of the protease inhibitor leupeptin against myocardial stunning
33. Calpain inhibitor I reduces infarct size and DNA fragmentation of myocardium in ischemic/reperfused hearts
34. The multiple organ or system failure syndrome
35. Relationship between tumor necrosis factor-alpha and neutrophils in endotoxin-induced liver injury
36. The multiple organ dysfunction syndrome caused by endotoxin in the rat: Attenuation of liver dysfunction by inhibitors of nitric oxide synthase
37. Effect of calpain inhibitor I, an inhibitor of the proteolysis of I kappa B, on the circulatory failure and multiple organ dysfunction caused by endotoxin in the rat
38. Antiinflammatory effects of mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger, in carrageenan-induced models of inflammation
39. Dissociation of lipopolysaccharide-mediated induction of nitric oxide synthase and inhibition of DNA synthesis in RAW 264.7 macrophages and rat aortic smooth muscle cells
40. Efficacy of agonist-stimulated MEK activation determines the susceptibility of mitogen-activated protein (MAP) kinase to inhibition in rat aortic smooth muscle cells
41. Comparative specificity and kinetic studies on porcine calpain I and calpain II with naturally occurring peptides and synthetic fluorogenic substrates
42. The role of cysteine proteases in hypoxia-induced rat renal proximal tubular injury
43. A membrane-permeable radical scavenger reduces the organ injury in hemorrhagic shock
44. Activation of NFκB requires proteolysis of the inhibitor IκB-α: Signal-induced phosphorylation of IκB-α alone does not release active NFκB
45. Role of transcription factor NF-κB/Rel in induction of nitric oxide
46. Proteolytic processing of nuclear factor kappa B by calpain in vitro
47. Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide
48. Invited opinion: Role of nitric oxide in hemorrhagic, traumatic and anaphylactic shock and thermal injury
49. Selective inhibition of the activity of inducible nitric oxide synthase prevents the circulatory failure, but not the organ injury/dysfunction, caused by endotoxin
50. Characterization and hormonal regulation of the promoter of the rat prostaglandin endoperoxide synthase 2 gene in granulosa cells. Identification of functional and protein-binding regions
51. Structure of the human cyclo-oxygenase-2 gene
52. Involvement of reactive oxygen intermediates in cyclooxygcnasc-2 expression induced by intcrleukin-1, tumor necrosis factor-α, and lipopolysaccharidc
53. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1
54. Chloroquine attenuates hemorrhagic shock-induced immunosuppression and decreases susceptibility to sepsis
55. Effects of inhibitors of cyclo-oxygenase-2 on the hypotension and multiple organ dysfunction caused by endotoxin: A comparison with dexamethasone
56. NMDA receptor linked cytoskeletal proteolysis in hippocampus
57. Inhibition of proteolysis protects hippocampal neurons from ischemia
58. Calpain is activated during hypoxic myocardial cell injury
59. The role of calcium activated neutral protease in myocardial cell injury in hypoxia